Rodin Therapeutics adopts Qlucore Omics Explorer
16 June 2017
Rodin Therapeutics, a venture-backed biotechnology company that develops therapeutics for neurological disorders has announced that it uses Qlucore Omics Explorer to characterise its compounds response to treatment.